[A clinical analysis of 64 cases of pemphigus].

Authors: He Z,Wang B,Yu B,
Address: PUMC Hospital, CAMS and PUMC, Beijing 100730.
Journal: Zhongguo Yi Xue Ke Xue Yuan Xue Bao.

Publication: 1998 Apr;20(2):144-7.

abstract

OBJECTIVE:

Reasonable therapeutic dosage regimen for pemphigus are analyzed to find the factors related to prognosis.

METHODS:

A retrospective study is made on 64 cases of pemphigus who were admitted to our hospital between 1986-1996.

RESULTS:

Sixty-two of 64 cases with pemphigus were treated with systemic administration of corticosteroids. The average dosage of prednisone for controlling the diseases were 0.958 mg.kg-1.d-1 for mild-type of pemphigus (12 cases) and 1.145 mg.kg-1.d-1 for severe-type (50 cases) respectively. Furthermore, 26 of 62 cases were treated with corticosteroids only, and the average dosage of prednisone for controlling the diseases was 1.072 mg.kg-1.d-1 while in 36 cases treated with corticosteroids combined with immunosuppressors, the average dosage of prednisone was 1.178 mg.kg-1.d-1. The rate of side-effects and complications were 15.4% in patients with corticosteroids alone and 36.1% in patients with combined therapy. Six of eight patients who died were diagnosed pemphigus vulgaris and seven with a course of disease less than 3 years.

CONCLUSIONS:

We recommend a moderate to high dosage of corticosteroids be the first choice to control pemphigus. Those who were effective with steroids are not recommended to use additional immunosuppressors. Patients with pemphigus vulgaris usually have a poor prognosis while those who could survived more than 4 years usually have a better outcome.

Related Articles
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Am J Clin Dermatol. 2007
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M, Kolacinska-Strasz Z, Sulej J, Labecka H, Cwikla J, Natorska U, Blaszczyk M. Am J Clin Dermatol. 2007; 8(2):85-92.
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Hautarzt. 1985
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Smolle J. Hautarzt. 1985 Feb; 36(2):96-102.
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Int J Dermatol. 2005
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK, Sharma NL, Sharma RC, Garg G. Int J Dermatol. 2005 Oct; 44(10):821-7.
Review Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases.
Oral Surg Oral Med Oral Pathol Oral Radiol ...
Review Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases.
Robinson JC, Lozada-Nur F, Frieden I. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct; 84(4):349-55.
Review Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
J Oral Pathol Med. 2000
Review Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
Mignogna MD, Lo Muzio L, Mignogna RE, Carbone R, Ruoppo E, Bucci E. J Oral Pathol Med. 2000 Apr; 29(4):145-52.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.